Comment on 25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

While sales of the blockbuster drug nearly doubled, the results still fell short of analysts’ expectations as the company faces competition from Eli Lilly. Danish drugmaker Novo Nordisk, the creator of Ozempic and Wegovy, announced a shocking statistic Thursday: Over 25,000 people begin Wegovy each week. The number is five times larger than the numbers from December—about 5,000 new users a week.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News